The effect of raloxifene on breast MRI volume in premenopausal women at increased risk for invasive breast cancer

被引：0
|
作者：
Eng-Wong, J.
Chow, C. K.
Orzano, J.
Venzon, D.
Zujewski, J.
Yao, J.
Prindiville, S.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] Warren Gen Hosp, Warren, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1518
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer
    Eng-Wong, J.
    Reynolds, J. C.
    Venzon, D.
    Liewehr, D.
    Gantz, S.
    Danforth, D.
    Liu, E. T.
    Chow, C.
    Zujewski, J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10): : 3941 - 3946
  • [2] Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer
    Eng-Wong, Jennifer
    Orzano-Birgani, Jennifer
    Chow, Catherine K.
    Venzon, David
    Yao, Jianhua
    Galbo, Claudia E.
    Zujewski, Jo Anne
    Prindiville, Sheila
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (07) : 1696 - 1701
  • [3] Raloxifene prevents breast cancer in women at increased risk
    不详
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (04) : 192 - 194
  • [4] Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk
    Lippman, Marc E.
    Cummings, Steven R.
    Disch, Damon P.
    Mershon, John L.
    Dowsett, Sherie A.
    Cauley, Jane A.
    Martin, Silvana
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5242 - 5247
  • [5] Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk
    Grady, Deborah
    Cauley, Jane A.
    Geiger, Mary Jane
    Kornitzer, Marcel
    Mosca, Lori
    Collins, Peter
    Wenger, Nanette K.
    Song, Jingli
    Mershon, John
    Barrett-Connor, Elizabeth
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (12) : 854 - 861
  • [6] Effect of raloxifene on menstrual cycle length and quality of life in premenopausal women at high risk for invasive breast cancer.
    Eng-Wong, J
    Stratton, P
    Forman, M
    Venzon, D
    Remaley, A
    Zujewski, JA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1300S - 1300S
  • [7] Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
    Vogel, Victor G.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2008, 3 (04): : 601 - 609
  • [8] A phase 2 trial of raloxifene in premenopausal women at high risk for developing invasive breast cancer.
    Zujewski, J
    Eng-Wong, J
    Reynolds, J
    Venzon, D
    Schmidt, E
    Chow, C
    Premkumar, A
    Merino, MJ
    Goldspeil, B
    Forman, M
    Stratton, P
    Klein, P
    Mershon, J
    Liu, ET
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S108 - S108
  • [9] Effect of raloxifene on invasive breast cancer incidence by baseline breast cancer risk in postmenopausal women at risk for major coronary events.
    Geiger, M. J.
    Song, J.
    Dowsett, S. A.
    Barrett-Connor, E.
    Cauley, J.
    Grady, D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S169 - S169
  • [10] MRI for screening women with an increased risk of breast cancer
    Kuhl, C.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 53 - 53
12345